Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”

Added Benefit of Raxibacumab to Antibiotic Treatment of Inhalational Anthrax

(2014) Thi-Sau Migone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits

(2013) Alfred Corey et al.   Toxins

Key aspects of the molecular and cellular basis of inhalational anthrax

(2011) Christopher K. Cote et al.   MICROBES AND INFECTION

Monoclonal Antibody Therapies against Anthrax

(2011) Zhaochun Chen et al.   Toxins

Progress and novel strategies in vaccine development and treatment of anthrax

(2010) Theodor Chitlaru et al.   IMMUNOLOGICAL REVIEWS

Raxibacumab

(2010) Sohini Mazumdar   mAbs

Raxibacumab for the Treatment of Inhalational Anthrax

(2009) Thi-Sau Migone et al.   NEW ENGLAND JOURNAL OF MEDICINE